Trial Profile
Combination of Rituximab and NK Immunotherapy for B Lymphoma
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications B-cell lymphoma
- Focus Therapeutic Use
- 10 Sep 2019 Status changed from recruiting to completed.
- 27 Jul 2016 New trial record